Björn Erlandsson
Keine laufenden Positionen mehr
Karriereverlauf von Björn Erlandsson
Ehemalige bekannte Positionen von Björn Erlandsson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DUNI AB | Corporate Officer/Principal | - | - |
| Pharmacia & Upjohn, Inc. | Corporate Officer/Principal | - | - |
| ERICSSON | Corporate Officer/Principal | - | - |
SCA Molnlycke Clinical Products AB
 SCA Molnlycke Clinical Products AB Medical SpecialtiesHealth Technology SCA Molnlycke Clinical Products AB provides medical and clinical products. The company is headquartered in Gothenburg, Sweden | Corporate Officer/Principal | - | - |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Finanzdirektor/CFO | 01.01.2010 | - |
Ausbildung von Björn Erlandsson
| Stockholm School of Economics | Undergraduate Degree |
Statistik
International
| Schweden | 5 |
| Vereinigtes Königreich | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Corporate Officer/Principal | 4 |
| Director of Finance/CFO | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Electronic Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ERICSSON | Electronic Technology |
| DUNI AB | Consumer Durables |
| Private Unternehmen | 3 |
|---|---|
Albireo Ltd.
Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Health Technology |
SCA Molnlycke Clinical Products AB
SCA Molnlycke Clinical Products AB Medical SpecialtiesHealth Technology SCA Molnlycke Clinical Products AB provides medical and clinical products. The company is headquartered in Gothenburg, Sweden | Health Technology |
| Pharmacia & Upjohn, Inc. | Health Technology |
- Börse
- Insiders
- Björn Erlandsson
- Erfahrung
